Passage Bio Inc. (NASDAQ: PASG)
$0.7098
-0.0542 ( -7.09% ) 253.6K
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease.
Market Data
Open
$0.7098
Previous close
$0.7640
Volume
253.6K
Market cap
$47.26M
Day range
$0.7000 - $0.7970
52 week range
$0.4510 - $1.7900
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 10-q | Quarterly Reports | 63 | May 14, 2024 |
| ars | Annual reports | 1 | Apr 09, 2024 |
| def | Proxies and info statements | 4 | Apr 09, 2024 |
| 4 | Insider transactions | 1 | Mar 19, 2024 |
| 4 | Insider transactions | 1 | Mar 19, 2024 |
| 4 | Insider transactions | 1 | Mar 19, 2024 |
| 4 | Insider transactions | 1 | Mar 19, 2024 |
| 8-k | 8K-related | 46 | Mar 04, 2024 |
| 10-k | Annual reports | 89 | Mar 04, 2024 |
| 8-k | 8K-related | 14 | Feb 29, 2024 |